PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2026Current NeuropharmacologyOpen Access

Nanotechnology-Based Strategies for Glioblastoma: Diagnostic andTherapeutic Advances

View Full Paper
Ask AI
Bookmark
Share

Authors

VYVirendra Kumar YadavSTShazia TahiraJJJayant Jain

Discussion

Loading...

Member takes

Overview

Review shows nanotechnology improves treatment outcomes in glioblastoma, indicating potential to overcome blood-brain barrier and tumor heterogeneity.

Key Points

  • This review examines nanotechnology-based strategies to enhance diagnostics and therapeutics for glioblastoma.
  • Analysis of various nanomaterials including metallic, metal oxide, carbon-based, polymeric, and lipid-based nanoparticles.
  • Review of BBB penetration mechanisms and functionalization strategies.
  • Evaluation of nanocarrier-drug systems and their pharmacokinetics.
  • Nanotechnology improves selective drug delivery and enhances tumor targeting in glioblastoma.
  • Solid lipid nanoparticles and exosomes show promise in overcoming therapeutic resistance.
  • Innovative strategies provide real-time monitoring and controlled release within the tumor microenvironment.

Cite This Study

Yadav et al. (2026) studied this question.

synapsesocial.com/papers/69bf393dc7b3c90b18b4391bhttps://doi.org/10.2174/011570159x399694251208060709
View Full Paper
Ask AI
Bookmark
Share